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Background: This study compared the performance of five commercially available kits in extracting total RNA from
small eukaryotic tissue samples (<15 mg). Total RNA was isolated from fathead minnow (Pimephales promelas)
tissues (spleen, blood, kidney, embryo, and larvae) using the Qiagen RNeasy® Plus Mini, Qiagen RNeasy® Plus
Universal, Promega Maxwell® 16 LEV simplyRNA, Ambion MagMAX™-96 and Promega SimplyRNA HT kits. Kit
performance was evaluated via measures of RNA quantity (e.g., total RNA amount) and quality (e.g., ratio of
absorbance at 260 and 280 nm, RNA integrity number (RIN), presence of gDNA).
Results: With the exception of embryos, each kit generally extracted ≥5 μg of total RNA from each sample. With
regard to RNA quality, the RINs of RNA samples isolated via the Plus Mini and Maxwell® 16 kits were consistently
higher than those of samples extracted via the remaining three kits and for all tissues, these kits produced intact
RNA with average RIN values ≥7. The Plus Universal and SimplyRNA HT kits produced moderately degraded (RIN
values <7, but ≥5), while the RNA recovered via the MagMAX™ kit tended to exhibit a high degree of degradation
(RIN values <5).
Conclusions: Each kit was generally capable of extracting the amount of RNA required for most downstream gene
expression applications suggesting that RNA yield is unlikely to be a limiting factor for any of the kits evaluated.
However, differences in the quality of RNA extracted via each of the kits indicate that these kits may differ in their
ability to yield RNA acceptable for some applications. Overall, the findings of this study demonstrate that there are
practical differences between commercially available RNA extraction kits that should be taken into account when
selecting extraction methods to be used for isolating RNA designated for gene expression analysis.
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Fathead minnowBackground
Gene expression analysis is a well-established method by
which changes in the physiological status of cells and
tissues can be detected. Previous studies have shown
that extraction of high-quality RNA from tissue samples
is a key step in the collection of accurate and reliable
gene expression data via real-time quantitative PCR
(qPCR), hybridization microarrays and next generation
sequencing (NGS) technologies (i.e., RNA-Seq) [1-6].* Correspondence: m.jeffries@tcu.edu
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article, unless otherwise stated.Recovery of sufficient amounts of high-quality RNA
from small (<15 mg) and/or complex eukaryotic tissue
samples has historically been considered problematic
[7-9]. Several manufacturers have recently begun to
market kits designed to recover high-quality RNA from
these types of samples [10]; however, few studies have dir-
ectly compared the performance of commercially available
kits in isolating RNA from small tissue samples [11].
Although there are differences in the technologies that
commercially-available kits employ to isolate total RNA
from tissue samples, each uses the same general approach:
1) cell lysis and inhibition of ribonuclease (RNase) activity,
2) removal of DNA, and 3) isolation of total RNA (of
which 1-5% is mRNA). Most kits require that tissues beentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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RNase denaturing agent to lyse cells and inhibit RNase
activity. Removal of genomic DNA (gDNA) most often
involves the treatment of samples with DNase I enzyme;
however, some kits utilize non-enzymatic methods, in-
cluding liquid-liquid (e.g., gDNA eliminator solution)
extractions and solid-phase extractions (e.g., gDNA
eliminator spin columns). Several methods are available
for the isolation of RNA [12]; those most commonly
employed by commercially-available kits include liquid-
liquid extraction (e.g., phenol-chloroform, TRIzol, etc.) or
solid-phase extraction using silica-based membrane or
paramagnetic bead technologies. Though many RNA iso-
lation kits require manual operation, kits designed for use
with liquid-handling robots are becoming more readily
available due to an increased demand for high-throughput
assays.
Regardless of the procedure used for RNA isolation, it
is necessary to determine the quantity of the recovered
RNA prior to downstream gene expression analysis [13].
Quantitation of RNA can be done via spectrophotometry
(UV) or fluorometry (RNA specific dye). The amount of
RNA required for downstream analysis depends upon
the method utilized for quantifying gene expression. For
example, the total RNA amount required for first-strand
cDNA synthesis is in the picogram (pg) to nanogram (ng)
range [14], while the amount required for microarray ana-
lysis is often in the microgram (μg) range [15].
In selecting an RNA isolation kit, not only must the
ability of the kit to recover the required amount of total
RNA be taken into consideration, but also the ability of
the kit to recover RNA meeting specific quality criteria.
Total RNA samples to be used in gene expression ana-
lysis should be: 1) free of proteins and contaminants that
can inhibit downstream molecular analyses, 2) intact
and free of nucleases (that can lead to subsequent deg-
radation) and 3) free from gDNA contamination [16].
The degree of sample contamination by proteins and other
contaminants is typically evaluated by determining ratios
of sample absorbance at 260 and 280 nm (A260:A280). This
ratio estimates the degree of contamination resulting from
protein and other contaminants (nucleic acids absorb at
260 nm, while proteins and other contaminants of con-
cern absorb at 280 nm) and total RNA samples with
values ≥1.8 are considered “pure” and acceptable for
downstream molecular analyses [17]. More recently, a
so-called “RNA integrity number (RIN)” or “RNA Qual-
ity Indicator (RQI)” has become the benchmark stand-
ard for RNA quality assessment. These metrics indicate
the degree of RNA fragmentation (with increasing
values representing more intact RNA) [18] and can be ob-
tained via lab-on-chip gel electrophoresis systems, derived
from LapChip® microfluidics technology (Caliper Life
Sciences, Inc.) and marketed by Agilent Technologies(Bioanalyzer2100) and BioRad (Experion). RNA with RIN
or RQI values ≥7-8 are typically considered an optimal
template for most downstream molecular applications
[1-3,7,19,20]; however, the minimum acceptable RIN
value depends on the type of analysis to be done. For
example, several studies have found RNA with RIN
values ≥5-5.5 to provide a suitable template for qPCR
reactions in cases where the amplicon length does not
exceed 200 bp [1-3,7]. With regard to the evaluation of
gDNA contamination, the standard approach involves
conducting qPCR reactions on “no-RT” or RT(−) samples
[13]. RT(−) samples are not subject to reverse transcrip-
tion and should thus, contain only RNA, which cannot be
amplified in qPCR reactions. Therefore, the detection of a
fluorescent signal in RT(−) samples indicates contamin-
ation by gDNA.
The goal of this study was to compare the performance
of several commercially available manual and automated
RNA extraction kits to isolate total RNA from small
amounts of vertebrate tissue samples (average mass
of <20 mg). To accomplish this goal, total RNA was
isolated from fathead minnow (Pimephales promelas)
tissues (blood, spleens, kidneys, embryos and larvae)
using the following kits: 1) RNeasy® Plus Mini Kit
(Qiagen, Valencia, CA), 2) RNeasy® Plus Universal Kit
(Qiagen), 3) Maxwell® 16 LEV simplyRNA Purification
Kit (Promega, Madison, WI), 4) MagMAX™-96 Total
RNA Isolation Kit (Ambion/Life Technologies, Grand
Island, NY) and 5) SimplyRNA HT System (Promega,
Beta test kit). The quantity and quality of RNA extracted
from each of these kits was compared in an effort to deter-
mine which kits were most appropriate for low- and high-
throughput RNA extractions of small tissues.
Methods
General experimental design
Figure 1 shows an overview of the experimental design
employed in this study. Briefly, blood, kidneys, spleens
were obtained from sexually-mature (~7 months old) male
fathead minnows. Embryos (~72-84 h post fertilization)
and whole larvae (~168 h post hatch) were also collected.
A total of eighty samples were randomly assigned for
RNA isolation by each of the commercially available kits
so that four samples of each tissue type were extracted by
each kit. A description of each of the selected kits includ-
ing the method by which each isolates RNA appears in
Table 1. Following the isolation procedures, the quantity
and quality of RNA in each sample was evaluated.
Tissue samples
All animal procedures in this study were approved by
Miami University’s Institutional Animal Care and Use
Committee. Fish were obtained from Miami University’s
fathead minnow colony. Blood, kidneys and spleens were
Figure 1 Visual description of the experimental design utilized to evaluate the performance of the Plus Mini, Plus Universal, Maxwell®,
MagMAXTM and SimplyRNA HT RNA extraction kits.
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minnows following euthanasia via a lethal dose of MS-222.
To obtain blood, the caudal peduncle was severed,
blood was collected in a heparinized microhematocrit
tube, transferred to 1.5 mL microcentrifuge tube and
centrifuged to separate plasma, which was subsequently re-
moved and discarded. Embryos (~72-84 h post fertilization,
n = 20) and whole larvae (~168 h post hatch, n =20) were
also sampled for analysis. All tissues were weighed immedi-
ately upon collection and masses are reported in Table 2.Table 1 Descriptions of the five commercial kits selected for i
Kit name (Catalog #) General description
Qiagen RNeasy® Plus Mini (#74134) Manual Operationa; Guanidine-isothio
Silica membrane-based RNA purificat
Non-enzymatic DNA elimination
Qiagen RNeasy® Plus Universal Mini
(#73404)
Manual Operationa; Phenol-guanidine
membrane-based RNA purification, N
DNA elimination
Promega Maxwell® 16 LEV simplyRNA
Purification (#AS1280)
Automated Operation; Guanidine-thio
Paramagnetic bead-based RNA purifica
DNA elimination
Ambion MagMAX™-96 Total RNA
Isolation (#AM1830)
Automated Operationb; Guanidinium th
lysis, Magnetic bead-based RNA purifica
DNA elimination
Promega SimplyRNA HT System
(Beta test kite)
Automated Operation; Guanidine-thio
Paramagnetic bead-based RNA purifica
DNA elimination
aThis kit can be automated on the Qiagen QIAcube robotic workstation.
bThis kit can be used manually.
cFor the Plus Mini, Plus Universal and Maxwell® kits, an elution volume of 30 μL wa
volume of 50 μL was used for RNA isolated from spleens and kidneys. Elution volum
and 50 μL, respectively.
dList price in June 2013; Prices are for the kits only and do not include the costs of
eBeta test kit of a new 96-well format high throughput, RNA purification system. FinTissues were flash frozen in liquid nitrogen and stored
at −80°C until RNA isolation.
RNA extraction
For each of the kits tested, tissues were homogenized
in the manufacturer supplied homogenization/lysis buffer
with a Misonix Microson XL-2000 Ultrasonic Cell Dis-
ruptor (QSonica, LLC., Newtown, CT). The specifications
of the Plus Mini, Plus Universal, Maxwell® and Sim-
plyRNA HT kits were such that tissues did not requirenclusion in this study
Kit specifications Cost/sample (USD)d
cyanate lysis,
ion,
Tissue Mass: ≤30 mg $6.02
Minimum Elution Volume: 30 μLc
lysis, Silica
on-enzymatic
Tissue Mass: ≤50 mg $6.86
Minimum Elution Volume: 30 μLc
cyanate lysis,
tion, Enzymatic
Tissue Mass: ≤50 mg $5.25
Minimum Elution Volume: 30 μLc
iocyanate-based
tion, Enzymatic
Tissue Mass: ≤5 mg $3.19
Minimum Elution Volume: 20 μL
cyanate lysis,
tion, Enzymatic
Tissue Mass: 5–300 mg $3.50-5.25
Minimum Elution Volume: 30 μL
s used for RNA extracted from blood, embryos and larvae, while an elution
es for all tissues extracted via the MagMAX™ and SimplyRNA HT kits were 55
equipment and reagents not supplied with the kit.
al specifications in development.
Table 2 The average (± standard deviation) masses of
tissues subject to RNA extractions via each kit
Blood Spleen Kidney Embryo Larvae
Plus Mini 19.5 (4.0) 5.3 (2.9) 20.3 (8.0) 1.1 (0.04) 6.4 (0.6)
Plus Universal 14.8 (2.8) 3.5 (1.2) 14.0 (4.6) 1.1 (0.1) 5.9 (0.8)
Maxwell® 20.0 (7.6) 3.7 (1.7) 13.4 (6.2) 1.1 (0.03) 6.7 (1.1)
MagMAX™ 4.0 (0.7)a 1.7 (0.9) 3.8 (1.8)a 1.1 (0.1) 6.5 (0.5)
SimplyRNA HT 11.3 (3.8) 4.9 (3.4) 14.3 (7.9) 1.2 (0.1) 5.3 (1.9)
aTissues processed using the MagMAX™ kit were trimmed to achieve
manufacturer suggested tissues masses ≤5 mg.
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suggested tissue amounts. However, the mass of blood,
kidney and larvae samples designated for processing using
the MagMAX™ kit were often greater than the recom-
mended tissue amount of 5 mg. To account for this, the
blood and kidneys samples were trimmed (while frozen)
to achieve masses ≤5 mg. Given that the cellular compos-
ition of larvae is far from homogeneous and that the mass
of larvae was just above the recommended mass of 5 mg,
larvae were left intact. For each tissue type, statistical ana-
lysis was conducted to determine if there were differences
in the masses of tissues designated for extraction via each
of the kits. Tissues that were trimmed for use with the
MagMAX™ kit were excluded from this analysis. For each
tissue type, statistical analysis confirmed that there were
no significant differences in the amount of starting mater-
ial processed by each kit (ANOVA, p >0.13 in all cases;
Table 2).
RNA extractions using the Plus Mini and Plus Universal
kits were performed manually. Extractions using the
Maxwell® kit were performed on a Promega’s robotics
platform, the Maxwell® 16 Research System, while those
using the MagMAX™ and SimplyRNA HT kits were per-
formed on a Beckman Coulter BiomekFX robot equipped
with both an AP96 and a SPAN8 pod. The difference be-
tween the two robotics platforms is that the BiomekFX li-
quid handling robot can transfer liquids from one location
to another, whereas the Maxwell® 16 transfers the para-
magnetic beads – not the liquid. Manufacturer protocols
for the Plus Mini, Plus Universal were followed without
exception. Protocols for the Maxwell® kit were followed
with one exception - all samples were homogenized in
210 μL of homogenization solution, rather than the
recommended 200 μL, to ensure adequate volumes of
homogenate for subsequent procedures. The method
for Simply RNA HT kit was optimized for the deck
configuration utilized in Miami University’s Center for
Bioinformatics and Functional Genomics, and the
method for the MagMAX™ kit was re-written from the
provided BiomekNX protocol to be compatible with the
BiomekFX and BiomekFX Software 3.3.14 (see Additional
file 1). With the MagMAX™ kit, we experienced problemswith the high viscosity of the magnetic bead mix included
with the kit. To overcome this problem, the bead mix was
diluted with additional lysis buffer (2.2 parts bead mix: 1
part lysis buffer) to ensure accurate pipetting by the Bio-
mekFX. To account for the dilution of the magnetic beads,
the amount of bead mixture utilized was increased from
20 μl to 30 μl per extraction to maintain manufacturer
recommended amounts of magnetic particles in each ex-
traction well.
Determination of RNA quantity and quality
Immediately following extraction, the total RNA concen-
tration and A260:A280 ratio of each sample was determined
via NanoDrop 2000 (Thermo Scientific). Total RNA
concentrations were converted to total amounts of RNA
extracted (μg) to account for differences in the required
elution volumes (see Table 1) of each kit. In addition,
because the amount of starting tissue can impact recovery,
the RNA recovered per mass of input tissue (μg RNA/mg
tissue) was also determined. RNA integrity numbers (RIN)
were determined using the RNA 6000 NanoKit for the
Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA)
per manufacturer protocol. The threshold cycle (Ct)
values were determined for each of the selected samples
with and without the additional DNase treatment and in
the corresponding RT(−) samples to determine the effect-
iveness of gDNA removal by each of the kits.
Evaluation of the effectiveness of gDNA elimination
Genomic DNA contamination was evaluated by conduct-
ing qPCR reactions on RT(−) samples [13]. Because the
RT(−) samples have not undergone reverse transcription,
they should contain only RNA. Hence, RT(−) samples that
are free of gDNA should not generate a fluorescent signal
during qPCR reactions. Here, one sample per tissue per
kit was randomly selected so that the ability of each kit to
remove gDNA could be evaluated. Total RNA samples
were considered gDNA free if the Ct values of the corre-
sponding RT (−) samples were ≥35, as these values are
typically considered noise [21,22]. The difference between
the Ct values of the RT (−) and RT (+) samples was also
determined. Differences ≥5 cycles are typically taken to in-
dicate that gDNA contamination will not adversely impact
qPCR results, as differences of this magnitude indicate
that <3% of the fluorescent signal generated during the
qPCR reaction results from the presence of gDNA [23].
Each of the RNA samples selected for this analysis was
subjected to a second DNase treatment via Invitrogen’s
DNA-free kit (Life Technologies, Grand Island, NY) per
manufacturer protocol to determine whether additional
DNase treatment was needed to supplement the DNA
removal procedures utilized by each of the kits. Because the
quantity of RNA extracted from embryos was less than the
amount required for use with the DNA-free kit, RNA
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only pooled samples were used in subsequent analysis.
Quantitative PCR
First-strand cDNA was synthesized for each of the RNA
samples selected for the additional DNase treatment, as
well as the corresponding total RNA samples prior to
the additional treatment. The iScript cDNA Synthesis
Kit (Bio-Rad Inc., Hercules, CA) was utilized for first-
strand cDNA synthesis. Briefly, reactions were carried
out via a PTC-100 thermal cycler (MJ Research, Waltham,
MA; 25°C for 5 min, 42°C for 30 min, 85°C for 5 min) with
0.1 μg total RNA in 7.5 μl nuclease-free water, 2 μl iScript
reaction mix and 0.5 μl iScript reverse transcriptase. The
resulting cDNA was diluted with nuclease-free water to a
final volume of 40 μL.
Following first-strand synthesis, the cDNA samples
(and corresponding total RNA samples) were shipped on
dry ice to Texas Christian University (Fort Worth, TX)
where qPCR was utilized to quantify the expression of
glutathione S-transferase (GST). All qPCR reactions were
performed in triplicate using a CFX Connect real-time
PCR detection system managed by CFX Manager Soft-
ware version 3.0 (Bio-Rad). Each 10 μl reaction contained
0.4 μL cDNA, 5 μL iQ SYBR-Green supermix (Bio-Rad)
and 300 nM of forward and reverse primer. The GST
primers were designed using CLC Genomics Workbench
6.8.4 (CLC bio, Cambridge, MA), synthesized by Integrated
DNA Technologies (Coralville, IA), and had the following
sequences: forward 5′-GGGCATTGGTGATCTAAC-3′
and reverse 5′-TTTTCAAACACAGGGAGG-3′. All reac-
tions were carried out in white shell/clear well PCR plates
(Bio-Rad) and the thermal cycling program consisted of an
activation step (95°C, 3 min) followed by 40 cycles of de-
naturing (95°C, 10 sec) and annealing (50°C, 45 sec). The
threshold cycle (Ct) values were determined for each of the
selected samples with and without the additional DNase
treatment and in corresponding RT (−) samples.
Data analysis
For each tissue type, significant differences in the quan-
tity (i.e., total RNA amount and mass-adjusted total
RNA amount) and quality (i.e., A260:A280 ratio and RIN
value) of RNA extracted using each kit were evaluated
via one-way analysis of variance (ANOVA, JMP Pro
10.0.0, SAS Institute) followed by Tukey’s multiple com-
parisons tests. In cases where the assumption of homo-
geneity of variances was not met, a Welch ANOVA
followed by Wilcoxon multiple comparisons tests was
conducted. Kit precision was evaluated by testing for
unequal variances (Levene’s test) between each of the
RNA quantity and quality parameters measured and
through the calculation of coefficients of variation (%CV).
Statistical significance was declared at p <0.05.The ability of each kit to produce RNA meeting qual-
ity and quantity criteria likely to be sufficient for qPCR,
microarray and NGS analysis was also assessed. Several
previous studies have established the minimum quantity
and quality of RNA designated for use in downstream
gene expression analysis [1,14,15,17,19,20]. To determine
whether the RNA isolated via the kits evaluated in this
study was sufficient for qPCR, microarray and NGS ana-
lysis, we determined whether the total amount of RNA
recovered, the A260:A280 ratios and the RIN values of
each sample met the minimum quality and quantity cri-
teria shown in Table 3.
Results and discussion
The performance of each RNA extraction kit was evalu-
ated for each tissue type. Significant differences in the
both the quantity and quality of RNA recovered by each
were detected (Figures 2 and 3). However, we recognize
that in several cases statistically significant differences
did not translate to practical differences in RNA quantity
or quality (i.e., the statistical analysis was more sensitive
than analytically relevant). For example, there were sig-
nificant differences in amount of RNA recovered from
blood, kidney and larvae by each kit (Figure 2, ANOVA,
p <0.001). However, the average amount of total RNA
recovered from these tissues (regardless of the kit used)
exceeded the minimum amount considered sufficient for
most downstream molecular applications, suggesting a
lack of practical difference between the kits with regard
to RNA yield from these tissue types. Likewise, there were
instances where statistical differences in RNA quality were
not necessarily indicative of practical differences in RNA
quality. This was particularly true for A260:A280 ratios. For
each tissue, there were significant differences in the A260:
A280 ratios of RNA recovered by each of the kits (Figure 3,
ANOVA/Welch ANOVA, p <0.03). However, for all but
embryos, the average A260:A280 ratios of total RNA
samples were ≥1.8 (Figure 3) indicating that each kit
was capable of producing “sufficiently pure” RNA suitable
for gene expression analysis by qPCR, microarray, or
NGS. Furthermore, an analysis to determine the minimal
detectable differences between the A260:A280 ratios of
samples was conducted and this analysis revealed that in
most cases, differences of <0.1 could be detected. Differ-
ences of this magnitude would not be considered relevant
from an analytical perspective. As such, subsequent dis-
cussions of kit performance will focus primarily on prac-
tical differences, rather than statistical differences.
Quantity and quality of RNA recovered via each of the kits
While some of our results are tissue-dependent, a few
general trends are particularly noteworthy with regard to
the quantity and quality of RNA recovered by each of
the kits. First, for each tissue (except embryos), the
Table 3 The minimum quantity and quality criteria for
RNA used to evaluate the suitability of RNA extracted via
each kit for analysis via real-time quantitative (qPCR),








qPCR ≥ 1 μg ≥ 1.8 ≥ 5
Microarray ≥ 5 μg ≥ 1.8 ≥ 7
NGS ≥ 1 μg ≥ 1.8 ≥ 7
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regardless of the kit used indicating that each of the kits
evaluated was capable of recovering sufficient amounts
of total RNA for analysis via qPCR or NGS technologies
(Figure 2, Table 3). Next, nearly all of the RNA samples
had A260:A280 ratios ≥1.8 (Figure 3). Only embryos ex-
tracted via the Plus Universal, Maxwell® and SimplyRT
HT kits and blood extracted via the Simply RT HT kit
had A260:A280 ratios <1.8 and these less-than-optimal ra-
tios were likely related to low concentrations (<15 ng/μL
in all cases) of nucleic acid in these samples [24], rather
than the ability of the kit to remove contaminants that
absorb at 280 nm. As such, it appears that there were
few practical differences between the kits with regard to
the removal of contaminants that absorb at 280 nm.
The most relevant differences in the RNA extracted
via each kit were related to the ability of the kits to con-
sistently extract intact total RNA. Figure 3 shows the
average RIN values obtained for each tissue extracted via
each of the kits, while Figure 4 provides a representative
example of the gel images obtained for samples ex-
tracted via each of the kits. The Plus Mini and Maxwell®
kits yielded the most intact (i.e., least degraded) total
RNA as evidenced by the fact that the majority of samples
extracted via these two kits (regardless of tissue type) had
average RIN values ≥7 (Figure 3). The performance of the
Plus Universal and SimplyRNA HT kits was similar
with regard to the integrity of the RNA yielded. For
most tissues, these two kits yielded RNA with average
RIN values ≥5 (but often <7) indicating RNA with a
moderate amount of degradation. The RNA extracted
via the MagMAX™ kit typically was found to be highly
degraded in most cases, as average RIN values were <5
for each of the tissue types except for larvae. These
findings demonstrate differences in the ability of each
kit to extract intact RNA and suggest that some kits
may be better suited for specific downstream applications
than others.
Finally, a majority of the samples tested negative for
gDNA contamination (Table 4), with the exception of
samples isolated via the MagMAX™ kit, suggesting that
most of the kits evaluated here offer near complete re-
moval of gDNA from tissue samples. In cases wheresamples tested positive for gDNA, an additional post-
extraction DNase I treatment was capable of eliminating
this contamination suggesting that the performance of kits
with less than optimal gDNA removal can be enhanced by
an additional DNA removal procedure.
Tissue specific considerations
Blood
In the current study, RNA was extracted from whole
blood samples and thus, the reported total RNA yields
include the amount of globin RNA in the sample. Blood
samples are frequently subject to globin reduction proce-
dures prior to RNA extraction; therefore, it is reasonable
to suspect that the amount of total RNA recovered from
blood samples would be lower than those reported if a
globin reduction step had been included in the RNA
extraction procedure. A study by Mastrokolias et al.
[25] found that globin reduction procedures reduced
the total RNA content of samples by 5-9%. Furthermore,
Mastrokolias et al. [25] also found that globin reduction
led to a slight decrease in RIN values, as non-globin re-
duced samples had average RIN values of approximately
7.7, while those subject to globin reduction had average
RIN values of 7.3. Given these results, it is likely that glo-
bin reduction would not only reduce the quantity total
RNA obtained from blood samples, but also the quality of
the recovered RNA.
Spleens
Spleens are frequently considered a “difficult” tissue due
to their relatively high abundance of nucleases [26]
which makes the RNA present in spleen tissue more
prone to degradation. In the current study, we found
that the RNA from spleen samples tended to be less
intact than that from kidney, embryo or larvae samples.
For example, kidney and larvae samples extracted via the
Plus Mini and Maxwell® kits had average RIN values >9.
In contrast, spleen samples extracted with these kits had
average RIN values of 7.7 and 7.8, respectively. Though
the ultimate cause of these seemingly tissue-specific differ-
ences in the integrity of RNA recovered from is unknown,
it is possible that the inherent nuclease content spleen in-
deed made the RNA therein more subject degradation
than the RNA in kidney and larvae samples.
Embryos
For single embryos, the amount of RNA recovered (re-
gardless of the kit utilized) was relatively low in compari-
son to other tissues and ranged from an average of 0.21 to
1.38 μg. The Plus Universal and MagMAX™ kits were
capable of extracting ≥1 μg total RNA, an amount often
suitable for qPCR and NGS analysis. However, there
were differences in the quality of RNA obtained using
these kits. Specifically, the Plus Universal kit produced
Figure 2 (See legend on next page.)
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Figure 2 The quantity of RNA extracted from fathead minnow tissues using five commercially available RNA extraction kits. The RNA
amounts shown in panels on the left (A, C, E, G and I) reflect the total amount of RNA recovered (ng), while the RNA amounts reported in
panels on the right (B, D, F, H and J) indicate the amount (ng) of RNA recovered per mass (mg) of tissue. The reported p-values were obtained
by one-way ANOVA, except for those denoted by a “W”. The “W” indicates that significant differences in variance were detected and that analysis
was conducted via a Welch ANOVA. Error bars indicate standard deviation. Different letters above bars indicate significant differences in the
measured RNA quantity parameter between samples processed by each of the kits. Percentages reported in each bar are indicative of the
coefficient of variance.
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MagMAX™ kit yielded highly degraded RNA (average
RIN =3.8). Assuming that NGS analysis requires RNA
with RIN values ≥7, these results suggest that neither
the Plus Universal nor the MagMAX™ kit produces
RNA from single embryos that is suitable for NGS ex-
periments. Given that moderately degraded RNA can
often produce successful qPCR results, it is possible that
embryonic RNA extracted via the Plus Universal kit
may be acceptable for qPCR analysis. The suitability of
the Plus Mini, Maxwell® and SimplyRNA HT kits for
embryonic RNA extractions appears to limited by the
quantity of RNA yielded (<1 μg for each kit), not the
quality of RNA yielded (RNA ≥7 for RNA extracted
from the Plus Mini and Maxwell® kits). Given this,
coupled with the fact that extractions were performed
on single embryos, it is possible that the performance of
these kits could be improved by pooling embryos prior
to extraction. Fromm [11] found that not only the quan-
tity, but also the quality of RNA isolated from pooled
Gyrodactylus salaris samples (consisting of either 10 or
100 individuals) was greater than that from single
G. salaris, providing evidence that sample pooling can
be utilized to optimize RNA isolation.
The extraction of RNA for downstream gene expression
analysis
When determining whether an RNA sample is acceptable
for downstream gene expression analysis, the quantity and
quality of RNA are generally the primary factors consid-
ered. In order to evaluate the performance of each kit in
its ability to produce RNA suitable for qPCR, NGS and
microarray analysis, we established minimum RNA quan-
tity and quality criteria specific to each type of analysis
(Table 3). With regard to RNA quantity, the total RNA
amount required for first-strand cDNA synthesis and thus,
qPCR and NGS is typically in the picogram (pg) to nano-
gram (ng) range [14]. In contrast, the labeling protocols
for microarray analysis frequently require ≥5 μg of total
RNA [15]. Like RNA quantity, the RNA quality required
for gene expression analysis is dependent upon the
method used to quantify expression. To evaluate the abil-
ity of each kit to produce RNA of suitable quality for
qPCR, NGS and microarray experiments, we assumed that
samples with RIN values ≥5 met the minimum qualitycriteria for analysis via qPCR and that those with values ≥7
met the minimum quality criteria for analysis via micro-
array or NGS analysis (Table 3). Though the assump-
tions were made based upon several accounts in the
literature [1-3,7,19,20], it would be naïve to assume that
the RIN value criteria set here is universally applicable
and thus, we recommend that individual labs establish
RIN value criteria more specific to their experimental
conditions (i.e., sample type, quantitation method, ampli-
con length, etc.).
qPCR analysis
Embryos aside, the Plus Universal and MagMAX™ kits
generally yielded higher amounts of RNA per mg of
tissue than the other kits, while the SimplyRNA HT kit
consistently yielded the lowest amount of RNA. Despite
significant differences in the quantity of RNA recovered
by each kit, the amount of RNA recovered from each
tissue sample was ≥1 μg, independent of the kit used -
with the exception of blood extracted via the SimplyRNA
HT kit (average yield of 1.74 ± 1.7 μg). Our results indicate
that each of the kits tested is likely to extract quantities of
total RNA sufficient for most qPCR. A closer examination
of the quality of RNA extracted using each of these kits,
revealed that the Plus Mini, Plus Universal and Maxwell®
kits recovered RNA with A260:A280 ratios ≥1.8 and RIN ≥5
from blood, spleen, kidney and larvae indicating that RNA
extracted from these tissues via these kits is acceptable for
qPCR. Likewise, the SimplyRNA HT kit extracted RNA
meeting the quantity and quality criteria for qPCR analysis
from spleen, kidney and larvae; though in our hands, the
ability of this kit to extract suitable RNA from blood sam-
ples was less consistent. The quality of RNA extracted
from the larval samples via the MagMAX™ kit met the
minimum quality criteria for qPCR (A260:A280 ratios >1.8
and RIN value >5). However, none of the RNA samples
extracted from blood, spleens and kidneys met these
criteria suggesting that the MagMAX™ kit may be limited
in its ability to extract intact RNA.
Microarray and NGS analysis
Whereas each of the kits except the MagMAX™, were
capable of isolating RNA meeting the criteria for qPCR
analysis, only the Plus Mini and Maxwell® kits were
consistent in their ability to isolate RNA meeting the
Figure 3 (See legend on next page.)
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Figure 3 The quality of RNA extracted from fathead minnow tissues using five commercially available RNA isolation kits. The panels on
the left (A, C, E, G and I) show the 260/280 ratios of RNA extracted using each kit; the dashed lines on each panel represents a 260/280 ratio of
1.8 (the value above which RNA is considered to be “pure”). The panels on the right (B, D, F, H and J) show the RNA integrity number (RIN); the
dashed line represents a RIN of 5 (the minimum acceptable RIN for qPCR analysis), while the dotted line shows a RIN of 7 (the minimum recommended
RIN for microarray and next generation sequencing analyses). Reported p-values were obtained by one-way ANOVA, except for those denoted by a “W”.
The “W” indicates that significant differences in variance were detected and that analysis was conducted via a Welch ANOVA. Error bars indicate
standard deviation. Different letters above bars indicate significant differences in the measured RNA quantity parameter between samples processed
by each of the kits. Percentages reported in each bar are indicative of the coefficient of variance. RIN values were not measurable (indicated by “nm”)
in RNA extracted from embryos using the SimplyRNA HT kit due to low RNA concentrations.
Sellin Jeffries et al. BMC Biotechnology 2014, 14:94 Page 10 of 13
http://www.biomedcentral.com/1472-6750/14/94assumed criteria for microarray analysis. Nearly all of
the RNA extracted from blood, spleen, kidney and larvae
samples by these two kits contained RNA of acceptable
quantity (1 and 5 μg total RNA for NGS and microarray
analysis, respectively) and quality (RIN values ≥7). Like-
wise, the SimplyRNA HT had similar performance char-
acteristics for kidney and larvae samples with the
majority of samples fulfilling the criteria for microarray
and NGS analysis. However, this kit was less consistent
in its ability to extract RNA from blood and spleen as
the majority of the blood and spleen RNA samples ex-
tracted with this kit did not meet the minimum quantity
requirements for microarray analysis. Furthermore, the
majority of spleen samples isolated with this kit did notFigure 4 A representative example of the gel images produced durin
composite gel image was generated from the results of RNA quality assess
the lane corresponding to the sample that best represented the “average”
represents the RIN value of the sample shown, while the numbers below r
samples extracted via each kit. Note that the lanes shown in the image we
the misalignment of the 18S and 28S bands between some of the lanes.fulfill the quality requirements for microarray or NGS
analysis. This indicates that the SimplyRNA HT may
not be sufficient for extracting blood and spleen samples
for use in microarray analysis; although, it is possible
that increasing the amount of starting material could
potentially overcome the low yield observed for the
SimplyRNA HT blood and spleen samples. It should
also be noted that these inconsistencies in the quantity
of RNA recovered via the SimplyRNA HT kit may be an
artifact of this kit being in the beta test stage (at time of
assay) and not being quite fully optimized for our
BiomekFX platform – to our knowledge, we were among
the first groups outside of Promega to evaluate this kit.
The Plus Universal kit consistently produced RNAg RNA quality checks performed via the Bioanalyzer 2100. The
ments performed on RNA extracted from larvae samples. For each kit,
RNA yielded is included. The first number reported for each kit
epresent the mean RIN value (± standard deviation) for all larvae
re not obtained from samples run on the same Nanochip resulting in
Table 4 Ability of each kit to effectively remove DNA
from small tissue samples
Pre-DNase Post-DNase
no RT RT Difference no RT RT Difference
Plus Mini
Blood 33.65 31.71 1.94 > 40* 32.23 7.77†
Spleen 39.84* 28.62 11.22† 39.84* 29.59 10.25†
Kidney 38.06* 19.35 18.71† > 40* 23.41 16.59†
Embryo > 40* 27.82 12.18† > 40* 29.46 10.54†
Larvae > 40* 26.26 13.74† > 40* 27.86 12.14†
Plus Universal
Blood 33.27 32.87 0.40 > 40* 34.07 5.93†
Spleen 34.77 28.90 5.87† 39.92* 29.14 10.78†
Kidney 36.50* 21.54 14.96† > 40* 22.18 17.82†
Embryo 39.79* 29.23 10.56† > 40* 31.17 8.83†
Larvae > 40* 20.74 19.26† > 40* 28.79 11.21†
Maxwell®
Blood > 40* 34.19 5.81† > 40* 34.84 5.16†
Spleen > 40* 29.38 10.62† > 40* 30.25 9.75†
Kidney > 40* 20.52 19.48† > 40* 20.67 19.33†
Embryo 37.09* 26.41 10.68† > 40* 25.86 14.14†
Larvae > 40* 26.46 13.54† > 40* 27.55 12.45†
MagMAX™
Blood 29.79 28.11 1.68 39.02* 32.65 6.37†
Spleen > 40* 29.93 10.07† 38.04* 30.36 7.68†
Kidney 31.83 21.89 9.94† 39.74* 21.51 18.23†
Embryo 36.34* 22.57 13.77† > 40* 22.31 17.69†
Larvae 33.75 27.54 6.21† > 40* 28.17 11.83†
SimplyRNA HT
Blood > 40* 31.06 8.94† > 40* 31.55 8.45†
Spleen > 40* 28.11 11.89† > 40* 27.9 12.10†
Kidney > 40* 21.54 18.46† > 40* 21.94 18.06†
Embryoa - - - - - -
Larvae > 40* 26.22 13.78† > 40* 26.00 14.00†
The threshold cycle (Ct) values of samples subjected to the kit DNase
treatment only (pre-DNase) or to an additional DNase treatment, as well as
the corresponding “no RT” samples (see Methods for details). *represents no
RT samples with Ct values ≥35 and thus, considered gDNA free. †indicates
samples for which difference between the Ct values of the no RT and RT
samples was ≥5, an indicator of sufficient gDNA removal for qPCR gene
expression analysis.
aThe quantities of RNA isolated from embryos using the SimplyRNA HT kit
were less than the amount necessary for the first-strand synthesis protocol
used in this study; therefore, qPCR reactions could not be performed with
these samples.
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ples extracted with this kit had RIN values ≥7 suggesting
that the RNA recovered via this kit is subject to fragmen-
tation and may be less than optimal for microarray and
NGS applications.Effectiveness of kit DNA elimination
Expression analysis of samples prior to the additional
DNase treatment showed the RT (−) reactions conducted
with samples extracted via the Maxwell® and SimplyRNA
HT kits were gDNA free (as indicated by Ct values >35,
Table 4) suggesting that the DNA removal procedures
utilized by these kits (i.e., DNase I treatment) is effective
for the tissue types evaluated here. Similarly, the Plus
Mini and Plus Universal kits offered near complete re-
moval of DNA from most of the samples indicating that
the DNA removal procedure utilized by these kits (i.e.,
non-enzymatic removal) is sufficient for most tissues. In
contrast, the majority of the MagMAX™ samples evaluated
for gDNA contamination tested positive, indicating that
this kit is inconsistent in its ability to effectively remove
DNA. It should be noted that an additional DNAse I
treatment was effective in removing DNA from all of
the samples that tested positive for gDNA contamination.
Thus, the performance of kits with seemingly ineffective
gDNA removal capabilities can be easily augmented via
additional DNA removal procedures.
Some downstream molecular procedures do require
samples that are almost completely free of gDNA contam-
ination (i.e., NGS analysis in which a single contaminating
gDNA strand can be detected) [27]; however, not all mo-
lecular applications require this degree of gDNA removal.
For example, in qPCR reactions, slight gDNA contamin-
ation is acceptable if the presence of the gDNA does not
account for more than 3% of the fluorescent signal (indi-
cated by differences in the Ct values of RT(−) and RT(+)
samples of >5) [23]. A comparison of RT(−) and RT(+)
values revealed that for many of the samples that tested
positive for gDNA contamination, namely the spleen
sample from Plus Universal kit and the kidney and larvae
samples from the MagMAX™ kit, the level of gDNA
contamination was unlikely to impact the results of
qPCR as the difference between the RT(−) and RT(+) Ct
values was >5 in all cases. However, for blood samples ex-
tracted by the Plus Mini, Plus Universal, and MagMAX™
kits, the difference between the Ct values was well
under 5 indicating that the presence of gDNA in these
samples will negatively affect gene expression data ob-
tained via qPCR. As such, an additional DNase treat-
ment is likely required for blood samples extracted via
these kits regardless of the downstream molecular appli-
cation to be used.
Kit precision
A consideration of kit precision is important in evaluating
the overall performance of each kit. For each of the RNA
quantity and quality parameters measured, differences in
variance were evaluated. With regard to variation in the
amount of total RNA recovered by each kit, no significant
differences in variance were detected, with the exception
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with regard to the amount of RNA extracted were similar.
For embryos, significant differences in variances of the
amount of total RNA isolated were detected (Levene’s test,
p =0.004). An examination of the %CV for the amount of
RNA recovered by each kit showed that the Plus Universal
Kit and Maxwell® kits were the most consistent in their
ability to isolate RNA (%CV =6.9 and 16.1, respectively).
In contrast, the Plus Mini, MagMAX™ and SimplyRNA
HT kits were less consistent (%CV >25 in each case).
Given that many of the embryo RNA samples contained
amounts of RNA near the minimum amount required for
qPCR and NGS analysis (i.e., 1 μg), the precision of these
kits is of particular importance. This is borne out when
comparing the Plus Mini and Plus Universal kits, as the
average amount of embryonic RNA isolated by each of
these kits was >1 μg (Figure 2). However, a closer examin-
ation showed that 100% of the embryo samples extracted
via the Plus Universal kit, whereas only 25% of the
samples isolated by the Plus Mini kit contained, con-
tained >1 μg of total RNA.
With regard to RNA quality, there were differences in
the variance associated with the A260:A280 ratios for
blood, kidney, embryo and larval RNA samples isolated
via the five kits evaluated (Levene’s test, p <0.03 in each
case). Despite these differences in variance, the %CV asso-
ciated with the A260:A280 ratios for each of these tissues
extracted by each of the kits was ≤3% in all but one case,
suggesting acceptable consistency in the ability of each
of the kits to isolate “pure” RNA. The one exception to
this appears to be the SimplyRNA HT kit, as the %CV
associated with the A260:A280 ratios for blood RNA
samples was 10.6%. This in combination with the fact
that half of the blood samples extracted via this kit had
A260:A280 ratios <1.8 indicates that the SimplyRNA HT
kit lacked precision in isolating “pure” RNA from
blood samples. However, it is plausible that the higher
variance in A260:A280 ratios for blood RNA samples
isolated with the SimplyRNA HT kit is related to the
relatively low amount of RNA yielded from these samples,
as low A260:A280 ratios can result from low concentrations
of RNA [24].
Significant differences in the variance associated with
RIN values of RNA obtained via the kits were noted for
each tissue type (Levene’s test, p <0.04 in each case), ex-
cept for larvae. This result suggests that the kits differed
with regard to their consistency in extracting intact
RNA. An examination of %CVs revealed that the Plus
Mini, Plus Universal, and Maxwell® kits offered the
highest degree of consistency regardless of tissue type, as
the %CVs were < ~10. The MagMAX™ and SimplyRNA
HT kits offered suitable consistency for spleen and
larvae samples (%CV <10); however, these kits lacked
consistency for blood, kidney and embryo samples(%CV >25 in each case). Overall, these findings suggest
that the Plus Mini, Plus Universal, and Maxwell® kits
offer more precision in isolating intact RNA than the
MagMAX™ and SimplyRNA HT kits. The reduced pre-
cision associated with the MagMAX™ and SimplyRNA
HT kits may be related to the performance of the kits
themselves. Alternatively, it is possible that the observed
lack of consistency was related to the fact that both of
these kits were utilized in conjunction with the BiomekFX
robot. Thus, the possibility that the performance of the
robot introduced an additional source of variation cannot
be excluded.
Conclusion
In summary, we have compared the ability of five
commercially available RNA isolation kits to yield suf-
ficient amounts of high-quality RNA from small tissue
samples for downstream gene expression analysis. For
low-throughput RNA isolation, we found the perform-
ance of the Plus Mini and Maxwell® kits to be similar,
as both were consistent in their ability to extract rela-
tively large quantities of intact RNA. Given the similar
performance of these kits, considerations of cost and
technician time are warranted. With regard to cost, the
per sample costs associated with the Maxwell® kit is a
bit lower than that for the Plus Mini; however, the
Maxwell® kit must be used in conjunction with a
Maxwell® 16 Instrument (list price of ~ $24,000). The
amount of time required for RNA extractions via these
kits was not specifically measured in this study. How-
ever, Qiagen reports that the amount of time required
for the Plus Mini kit is 25 m [28] and we estimate that
Maxwell® kit requires ~75 m (~20 m ‘hands-on’ time
and 55 m processing time in the Maxwell® instrument).
As such, the Plus Mini kit appears to more cost- and
time-effective than the Maxwell® kit, though the auto-
mation of the Maxwell® kit is likely to reduce the possi-
bility of technician error. For high-throughput RNA
extraction, we found that for most tissues, the Sim-
plyRNA HT kit was able to isolate RNA that meets the
quantity and quality criteria for downstream analysis
via qPCR, microarray and NGS technologies. However,
this kit offered less precision than any of the low-
throughput kits with regard to the quality of RNA
extracted. At the time of this study, the SimplyRNA
HT system was at the end of beta testing, and future
refinements to the kit may increase yield quantity,
quality and precision. It should also be noted that RNA
extractions using the Plus Mini and Plus Universal kits
can be conducted with the QIACube robotics platform.
Additional studies aimed at evaluating the performance of
these kits on the QIACube platform are warranted, as are
inter-laboratory studies aimed at cross-validating the
results presented here.
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